Rationale and design of the direct oral anticoagulants for prevention of left ventricular thrombus after anterior acute myocardial infarction (APERITIF) trial-Reference-Cited by-同舟云学术

Rationale and design of the direct oral anticoagulants for prevention of left ventricular thrombus after anterior acute myocardial infarction (APERITIF) trial

Published:2023-12 Issue: Volume:266 Page:98-105
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Puymirat Etienne^ORCID,Soulat Gilles,Fayol Antoine,Mousseaux Elie,Montalescot Gilles,Cayla Guillaume,Steg Philippe Gabriel,Berard Laurence,Rousseau Alexandra,Drouet Élodie,Simon Tabassome,Danchin Nicolas

Funder

Bayer

Assistance Publique - Hôpitaux de Paris

Bayer Healthcare

Ministry of Health

Agence Nationale de la Recherche

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Left ventricular thrombus after acute myocardial infarction: screening, prevention, and treatment;McCarthy;JAMA Cardiol,2018

2. Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarction;Maniwa;Eur Heart J,2018

3. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

4. Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction;Weinsaft;J Am Coll Cardiol,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of embolic risk in left ventricular thrombus between nonischemic and ischemic cardiomyopathy: A nationwide database analysis;International Journal of Cardiology;2024-09

2. Rationale and design of the FRENch CoHort of myocardial Infarction Evaluation (FRENCHIE) study;Archives of Cardiovascular Diseases;2024-06

3. Emerging Trends in Left Ventricular Thrombus: A Comprehensive Review of Non-Ischemic and Ischemic Cardiopathies, Including Eosinophilic Myocarditis, Chagas Cardiomyopathy, Amyloidosis, and Innovative Anticoagulant Approaches;Diagnostics;2024-04-30